Reilly Financial Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Reilly Financial Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$6K	Buy	49 +8	+20%	+$1.05K	﹤0.01%	806
2021 Q3	$5K	Hold	41	–	–	﹤0.01%	746
2021 Q2	$7K	Buy	41 +18	+78%	+$3.12K	﹤0.01%	749
2021 Q1	$4K	Hold	23	–	–	﹤0.01%	825
2020 Q4	$4K	Hold	23	–	–	﹤0.01%	729
2020 Q3	$3K	Hold	23	–	–	﹤0.01%	720
2020 Q2	$3K	Hold	23	–	–	﹤0.01%	767
2020 Q1	$2K	Hold	23	–	–	﹤0.01%	791
2019 Q4	$3K	Hold	23	–	–	﹤0.01%	781
2019 Q3	$3K	Hold	23	–	–	﹤0.01%	795
2019 Q2	$3K	Hold	23	–	–	﹤0.01%	838
2019 Q1	$3K	Hold	23	–	–	﹤0.01%	859
2018 Q4	$3K	Hold	23	–	–	﹤0.01%	826
2018 Q3	$4K	Hold	23	–	–	﹤0.01%	859
2018 Q2	$4K	Hold	23	–	–	﹤0.01%	844
2018 Q1	$3K	Hold	23	–	–	﹤0.01%	846
2017 Q4	$3K	Hold	23	–	–	﹤0.01%	849
2017 Q3	$3K	Hold	23	–	–	﹤0.01%	843
2017 Q2	$4K	Buy	+23	New	+$3.52K	﹤0.01%	807
2013 Q3	–	Sell	-30	Closed	-$2K	–	770
2013 Q2	$2K	Buy	+30	New	+$1.83K	﹤0.01%	758

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Reilly Financial Advisors's JAZZ Position: Q4 2021 in Review

Reilly Financial Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 20% in Q4 2021, buying an estimated $1.05K and bringing the position to 49 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #806.

Reilly Financial Advisors first reported a position in JAZZ in Q2 2013 and has held it in 20 quarters since. The position peaked at $7K in Q2 2021. 454 funds tracked by Wall St. Rank hold JAZZ as of Q4 2021.

Reilly Financial Advisors held 49 shares of Jazz Pharmaceuticals worth $6K as of Q4 2021.
Reilly Financial Advisors bought 8 Jazz Pharmaceuticals shares in Q4 2021, an estimated $1.05K.
Jazz Pharmaceuticals made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #806 holding.
Reilly Financial Advisors first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 20 quarters since.
Reilly Financial Advisors's Jazz Pharmaceuticals position peaked at $7K in Q2 2021.
454 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2021.

Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.